Design and synthesis of CK2 inhibitors

Mol Cell Biochem. 2011 Oct;356(1-2):91-6. doi: 10.1007/s11010-011-0953-8. Epub 2011 Jul 13.

Abstract

A series of new polybrominated benzimidazoles and benzotriazoles has been synthesized and their influence on the activity of protein kinase CK2 was evaluated. It was revealed that the most active inhibitors are those with methyl or ethyl substituent at benzene ring, namely 5,6,7-tribromo-4-methyl-1H-benzotriazole (38, IC(50) 0.51 μM) and 5,6,7-tribromo-4-ethyl-1H-benzotriazole (40, IC(50) 0.16 μM). The derivatives with large aromatic or heterocyclic substituents connected to benzimidazole or benzotriazole scaffold appeared to be less potent inhibitors.

MeSH terms

  • Benzimidazoles / chemistry
  • Benzimidazoles / pharmacology
  • Casein Kinase II / antagonists & inhibitors*
  • Casein Kinase II / metabolism
  • Drug Design*
  • Humans
  • Inhibitory Concentration 50
  • Protein Kinase Inhibitors / chemical synthesis*
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology*
  • Triazoles / chemistry
  • Triazoles / pharmacology

Substances

  • 4,5,6,7-tetrabromobenzimidazole
  • 4,5,6,7-tetrabromobenzotriazole
  • Benzimidazoles
  • Protein Kinase Inhibitors
  • Triazoles
  • Casein Kinase II